Literature DB >> 11466246

Is the pulse rate useful in assessing risk of diabetic retinopathy and macular oedema? The Wisconsin Epidemiological Study of Diabetic Retinopathy.

T Y Wong1, S E Moss, R Klein, B E Klein.   

Abstract

AIM: To describe the relation between pulse rate and incident diabetic retinopathy.
METHODS: Population based cohort study of people with diabetes. Resting pulse rate was measured in 30 second intervals. Diabetic retinopathy was evaluated from masked gradings of fundus photographs.
RESULTS: People with higher pulse rates were more likely to have 4 year progression of retinopathy, progression to proliferative retinopathy, and incident macular oedema than those with lower pulse rates. However, these associations were attenuated after controlling for blood pressure, glycosylated haemoglobin, and other risk factors.
CONCLUSION: Pulse rate may be a clinical indicator of overall risk of diabetic retinopathy, but is not independently associated with the condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11466246      PMCID: PMC1724060          DOI: 10.1136/bjo.85.8.925

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry.

Authors:  P Greenland; M L Daviglus; A R Dyer; K Liu; C F Huang; J J Goldberger; J Stamler
Journal:  Am J Epidemiol       Date:  1999-05-01       Impact factor: 4.897

2.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1989-02

3.  The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors.

Authors:  R F Gillum
Journal:  Am Heart J       Date:  1988-07       Impact factor: 4.749

4.  The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema.

Authors:  R Klein; S E Moss; B E Klein; M D Davis; D L DeMets
Journal:  Ophthalmology       Date:  1989-10       Impact factor: 12.079

5.  Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations.

Authors:  P Palatini; E Casiglia; P Pauletto; J Staessen; N Kaciroti; S Julius
Journal:  Hypertension       Date:  1997-11       Impact factor: 10.190

6.  Retarding effect of lowered heart rate on coronary atherosclerosis.

Authors:  P A Beere; S Glagov; C K Zarins
Journal:  Science       Date:  1984-10-12       Impact factor: 47.728

7.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

8.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

9.  Cardiovascular autonomic neuropathy and proliferative diabetic retinopathy.

Authors:  D S Fong; J H Warram; L M Aiello; L I Rand; A S Krolewski
Journal:  Am J Ophthalmol       Date:  1995-09       Impact factor: 5.258

10.  The association between heart rate and blood pressure, blood lipids and other cardiovascular risk factors.

Authors:  G Wannamethee; A G Shaper
Journal:  J Cardiovasc Risk       Date:  1994-10
View more
  1 in total

1.  Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus.

Authors:  Graham S Hillis; Jun Hata; Mark Woodward; Vlado Perkovic; Hisatomi Arima; Clara K Chow; Sophia Zoungas; Anushka Patel; Neil R Poulter; Giuseppe Mancia; Bryan Williams; John Chalmers
Journal:  J Am Heart Assoc       Date:  2012-10-25       Impact factor: 5.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.